X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (68871) 68871
Newspaper Article (7705) 7705
Newsletter (7180) 7180
Magazine Article (679) 679
Book Chapter (277) 277
Book / eBook (158) 158
Dissertation (126) 126
Government Document (118) 118
Trade Publication Article (94) 94
Web Resource (66) 66
Book Review (43) 43
Transcript (40) 40
Report (37) 37
Reference (34) 34
Paper (28) 28
Conference Proceeding (25) 25
Streaming Video (14) 14
Publication (12) 12
Journal / eJournal (4) 4
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tuberculosis (52140) 52140
humans (50393) 50393
male (24869) 24869
female (24221) 24221
adult (20945) 20945
antitubercular agents - therapeutic use (16861) 16861
middle aged (16149) 16149
tuberculosis, pulmonary - drug therapy (13622) 13622
infectious diseases (12252) 12252
tuberculosis - drug therapy (10615) 10615
drug therapy (10384) 10384
research (9801) 9801
aged (8877) 8877
adolescent (8841) 8841
infections (7765) 7765
drug resistance (7608) 7608
diagnosis (6757) 6757
mycobacterium tuberculosis - drug effects (6379) 6379
health aspects (6249) 6249
antitubercular agents (6222) 6222
treatment outcome (6215) 6215
microbiology (6147) 6147
mycobacterium-tuberculosis (6128) 6128
risk factors (5958) 5958
immunology (5854) 5854
care and treatment (5811) 5811
child (5779) 5779
respiratory system (5666) 5666
hiv (5574) 5574
animals (5515) 5515
pulmonary tuberculosis (5306) 5306
mycobacterium tuberculosis (5264) 5264
drug therapy, combination (5189) 5189
patients (5183) 5183
medicine (4979) 4979
medical research (4873) 4873
human immunodeficiency virus--hiv (4762) 4762
analysis (4627) 4627
antitubercular agents - administration & dosage (4512) 4512
mycobacterium tuberculosis - isolation & purification (4499) 4499
medicine, general & internal (4478) 4478
isoniazid - therapeutic use (4368) 4368
young adult (4284) 4284
public health (4260) 4260
retrospective studies (4185) 4185
research article (4149) 4149
infection (4134) 4134
tuberculosis - epidemiology (4122) 4122
drugs (3967) 3967
mortality (3967) 3967
drug resistance in microorganisms (3908) 3908
antitubercular agents - pharmacology (3849) 3849
tuberculosis, multidrug-resistant - drug therapy (3802) 3802
tuberculosis - diagnosis (3784) 3784
epidemiology (3680) 3680
medicine, experimental (3673) 3673
child, preschool (3636) 3636
time factors (3611) 3611
rifampin - therapeutic use (3527) 3527
tuberculosis, pulmonary - diagnosis (3432) 3432
disease (3328) 3328
pharmacology & pharmacy (3277) 3277
prevalence (2972) 2972
aids (2969) 2969
infant (2959) 2959
microbial sensitivity tests (2919) 2919
antibiotics (2895) 2895
diagnosis, differential (2857) 2857
rifampin (2803) 2803
therapy (2793) 2793
multidisciplinary sciences (2720) 2720
hiv infections - drug therapy (2694) 2694
studies (2670) 2670
tuberculosis - prevention & control (2656) 2656
tuberculosis, pulmonary - microbiology (2653) 2653
mice (2611) 2611
tuberculosis, pulmonary - complications (2583) 2583
tuberculosis, pulmonary - epidemiology (2571) 2571
antitubercular agents - adverse effects (2569) 2569
hiv infections - complications (2561) 2561
mycobacterium tuberculosis - genetics (2515) 2515
bacteria (2507) 2507
sputum - microbiology (2491) 2491
public, environmental & occupational health (2473) 2473
acquired immune deficiency syndrome--aids (2470) 2470
follow-up studies (2438) 2438
tuberculosis - microbiology (2360) 2360
chemotherapy (2326) 2326
hospitals (2314) 2314
incidence (2309) 2309
tuberculosis - complications (2265) 2265
isoniazid (2262) 2262
science (2252) 2252
drug resistance, microbial (2242) 2242
prevention (2120) 2120
aged, 80 and over (2118) 2118
usage (2098) 2098
children (2077) 2077
hiv infection (1936) 1936
tuberculosis, multidrug-resistant - epidemiology (1895) 1895
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (74) 74
Online Resources - Online (25) 25
West Park Healthcare Centre - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
New College (Ivey) - Stacks (3) 3
St. Michael's Hospital - Stacks (3) 3
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Periodical Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Stacks (1) 1
St. Michael's Hospital - Online (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
West Park Healthcare Centre - Archives (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (74765) 74765
Russian (3283) 3283
French (2013) 2013
German (1725) 1725
Japanese (1460) 1460
Spanish (1078) 1078
Italian (696) 696
Polish (676) 676
Portuguese (648) 648
Chinese (376) 376
Romanian (348) 348
Dutch (122) 122
Croatian (118) 118
Turkish (91) 91
Ukrainian (73) 73
Danish (68) 68
Hungarian (68) 68
Korean (62) 62
Norwegian (57) 57
Serbian (52) 52
Swedish (52) 52
Czech (46) 46
Hebrew (42) 42
Slovak (26) 26
Finnish (23) 23
Arabic (10) 10
Bulgarian (10) 10
Persian (10) 10
Lithuanian (8) 8
Afrikaans (6) 6
Bosnian (6) 6
Indonesian (5) 5
Slovenian (4) 4
Belarusian (1) 1
Greek (1) 1
Hindi (1) 1
Icelandic (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pulmonary pharmacology, ISSN 0952-0600, 1988
Journal
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9738, pp. 367 - 387
Summary HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs... 
Internal Medicine | SOFT-TISSUE INFECTIONS | MEDICINE, GENERAL & INTERNAL | OPIOID SUBSTITUTION TREATMENT | HEPATITIS-C VIRUS | SMOKING-CESSATION PHARMACOTHERAPIES | CLINICAL-TRIAL | TREATMENT OUTCOMES | METHADONE-MAINTENANCE | ADMINISTERED ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV Infections - epidemiology | Humans | Drug Resistance, Bacterial | Narcotics - therapeutic use | Criminal Law | Anti-HIV Agents - administration & dosage | Hepatitis, Viral, Human - epidemiology | Drug Interactions | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Tuberculosis - drug therapy | Anti-HIV Agents - therapeutic use | HIV Infections - mortality | Substance-Related Disorders - mortality | Antitubercular Agents - therapeutic use | Mental Disorders - epidemiology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Comorbidity | AIDS-Related Opportunistic Infections - drug therapy | Evidence-Based Medicine | Narcotics - administration & dosage | Medication Adherence | Mental Disorders - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Bacterial Infections - epidemiology | HIV Infections - drug therapy | Substance-Related Disorders - drug therapy | Hepatitis, Viral, Human - drug therapy | Prisoners | Prevention | Complications and side effects | Drug addicts | Research | Drug therapy | Health aspects | HIV infection | Mental illness | Risk factors | Cardiovascular diseases
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2018, Volume 62, Issue 2
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 16, pp. 1492 - 1501
Journal Article
Biomaterials, ISSN 0142-9612, 2010, Volume 32, Issue 7, pp. 1986 - 1995
Abstract A composite scaffold drug delivery system (CS-DDS) for osteoarticular tuberculosis therapy has been prepared by loading bi-component drugs into a mesoporous silica nanoparticles (MSNs)-coated porous β... 
Advanced Basic Science | Dentistry | β-TCP scaffolds | Antitubercular drugs | Mesoporous silica nanospheres | Composite drug delivery system | Controlled release | MYCOBACTERIUM-TUBERCULOSIS | ANTITUBERCULOSIS DRUGS | MATERIALS SCIENCE, BIOMATERIALS | GLASS-CERAMIC SCAFFOLD | ENGINEERING, BIOMEDICAL | beta-TCP scaffolds | RIFAMPICIN | MICROPARTICLES | REPAIR | IN-VITRO ACTIVITIES | HEPATOTOXICITY | SUSTAINED-RELEASE | LIPOSOMES | Rifampin - pharmacokinetics | Nanocomposites - chemistry | Nanoparticles - chemistry | Mycobacterium tuberculosis - drug effects | Mycobacterium tuberculosis - pathogenicity | Liver - drug effects | Isoniazid - therapeutic use | Rifampin - therapeutic use | Rifampin - administration & dosage | Antitubercular Agents - therapeutic use | Cell Line | Rabbits | Kidney - drug effects | Isoniazid - pharmacokinetics | Silicon Dioxide - chemistry | Calcium Phosphates - chemistry | Isoniazid - administration & dosage | Animals | Antitubercular Agents - pharmacokinetics | Antitubercular Agents - administration & dosage | Biocompatible Materials | Mice | Porosity | Drug Delivery Systems - methods | Drug Delivery Systems - adverse effects | Drugs | Surgical implants | Biomedical materials | Drug delivery systems | Tuberculosis | Biocompatibility | Nanostructure | Scaffolds
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 362, Issue 8, pp. 697 - 706
Journal Article
Journal Article